OVARIAN HORMONAL STRESS AFTER MEDICAL ABORTION
Topicality: Abortion is an artificial termination of pregnancy that causes a serious change in the hormonal background. One of the modern most sparing methods of termination of pregnancy is considered to be medical termination of pregnancy in the early stages through the use of biologically active substances. After the termination of pregnancy, the body, which has begun preparing for carrying a child and lactation, is experiencing serious stress. No matter how gentle the method of termination of pregnancy is, it is still a serious psychological and physical trauma, hormonal stress and always presents a risk of serious complications. According to foreign and domestic scientific research, there is not enough research on the state of the pituitary gland and ovaries after a medical abortion, which was the purpose of our study.
The purpose of the study: to study the hormonal status of women after medical abortion
Research methods and materials. We observed 50 women who had no contraindications to pharmacological abortion in the post-abortion period after a medical abortion performed in an outpatient clinic with a delay in menstruation up to 63 days. All pregnant women were examined before medical abortion according to the clinical protocol of the MZRK
Results. The age of women who applied to the clinic for abortion was on average 26-30 years (38%). There were no contraindications for medical abortion among pregnant women. According to pregnancy parity, every second pregnant woman was multiparous, every third was multiparous, and every fifth was primiparous. According to the results of a clinical examination, the hemoglobin values were not lower than 100 g/l in 90%, only in 10% hemoglobin was within 95 g/l. According to the results of a smear for the degree of purity of the vagina, every second woman had a second degree of purity of the vagina, which is considered within the normal range. The third degree of purity of the vagina was found in 34% of pregnant women, and the fourth - in 16%. Observation of women during medical abortion showed no complaints. According to the results of the third visit, it was found that among 74% of women among early post-abortion complications in 2 (6%) pregnant women, ultrasound revealed a hematometer, which subsequently led to late complications - menstrual irregularities against the background of chronic endometritis. Before and after medical abortion, all women were determined hormonal status by ELISA. For 3 months, the patients kept a menstrual calendar, as well as ultrasound of the pelvic organs at the end of medical abortion and subsequently on the 5th day of the menstrual cycle to study the state of the endometrium and ovaries.
The novelty of the study: the study of the hormonal status of women will allow for the prevention of early ovarian failure among women at risk.
Practical application of the study: use of combined oral contraceptives after medical abortion for 3 months.
GulnaraZh. Sakhipova1, https://orcid.org/0000-0002-9062-0697
Nurgul A. Abenova1, https://orcid.org/0000-0003-0395-9025
1 NСJSC «West Kazakhstan medical university named after M. Ospanov»,
Aktobe s., Republic of Kazakhstan.
1. Абрамченко В.В., Гусева Е.Н. Медикаментозный аборт. Санкт-Петербург: «ЭЛБИ-СПБ», 2005. 288 с.
2. Айламазян Э.К., Кулаков В.И., Савельева Г.М. Акушерство. Национальное руководство, М. ГЭОТАР-Медиа, 2009. С. 332 339.
3. Белокриницкая Т.Е. и др. Сравнительная оценка клинического течения медикаментозного аборта с 200 мг и 600 мг мифепристона: проспективное когортное исследование // Акушерство и гинекология. 2014. 3. С. 81 86.
4. Дикке Г.Б., Яроцкая В.А., Ерофеева А.В. Стратегическая оценка политики, программ и услуг в сфере непланируемой беременности, абортов и контрацепции в Российской Федерации (Совместное исследование Министерства здравоохранения и социального развития РФ и ВОЗ) // Проблемы репродукции. 2010. 3. С. 92 97.
5. Доступность и безопасность аборта и контрацепции: проблемы общественного здравоохра-нения. Материалы международного семинара Fiapac. Москва, ГУ Научный центр акушерства, гинекологии и перинатологии РАМН, 2005. 335 с.
6. Кулаков В.И. Аборт в России: изменения последних 20 лет // Доступность безопасного аборта и контрацепции: проблемы общественного здравоохранения: междунар. семинар. М., 2005. С. 8 11.
7. Краснопольский В.И., Мельник Т.Н., Серова О.Ф. Безопасный аборт. М. ГЭОТ АР-Медиа, 2009. 37 с.
8. Медицинские критерии приемлемости методов контрацепции РФ. Москва, 2012. 242 с.
9. Прилепская В.Н., Куземина А.А. Аборт в I триместре беременности. М., ГЭОТАР-Медиа, 2010. 210 с.
10. Приказ Минздрава России от 12 ноября 2012г. 572н. Порядок оказания медицинской помощи по профилю «акушерство и гинекология (за исключением использования вспомогательных репродуктивных технологий)». https://minzdrav.gov.ru (Дата обращения: 08.02.2013)
11. Приказ Министерства здравоохранения и социального развития РФ от 17 мая 2007 г. N335 «О рекомендуемом образце информированного добровольного согласия на проведение искусственного прерывания беременности при сроке до 12 недель» https://www.dokipedia.ru. (Дата обращения: 17.05.216)
12. Серов В.Н. Гормональная контрацепция как метод реабилитации после абортов // Гинекология. 2010. №2. С. 26-28.
13. Серова О.Ф., Мельник Т.Н., Липовеяко Л.Н. Современные технологии прерывания беременности в ранние сроки // Вопросы гинекологии, акушерства и перинатологии. 2003. 2 (1). С. 87 90.
14. Савельева И.А. Медикаментозный аборт: практические вопросы // Эффективная фармакотерапия в акушерстве и гинекологии. 2010. №3. с. 22.
15. Яворовская К.А., Щедрина Р.Н., Петрович Е. Роль нарушений функции щитовидной железы в реализации программы экстракорпорального оплодотворения и переноса эмбрионов // Акушерство и гинекология. 2004. 6: 8–9.
16. American College of Obstetricians and Gynecologists. Practice bulletin no. 143: medical management of first-trimester abortion // Obstet. Gynecol. 2014. Vol. 123 (3). Р. 676-692
17. Achilles S.L., Reeves M.F. Society of Family Planning. Prevention of infection after induced abortion: release date October 2010: SFP Guideline 2010. Contraception. 2011. Vol. 83. Р. 295 309
18. Fischer М., Bhatnagar J., Guamer J. Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion // New England Journal of Medicine. 2005. Vol. 353. P. 2352 2360. 28-30
19. Gaffield M.E., Kapp N., Ravi A. Use of combined oral contraceptives post abortion // Contraception. 2009. Vol. 80. P. 355 362.
20. Hamoda H., Ashok P.W., Flett G.M., Templeton A. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation // BJOG. 2005. Vol. 112. P. 1102 1108.
21. Kulier R. et al. Medical methods for first trimester abortion. Cochrane Database of Systematic Reviews. 2011. Vol.1: CD002855
22. SPC [summary product characteristics] Mifegyne URL: http://www.medicmes.org.uk/emc/medicine/617 (accessed: 14.10.2015)
23. Tang O.S., Chan C.C., Ng E.H. et al. A prospective, randomized, placebocontrolled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation // Human Reproduction. 2003. Vol. 18 (11). Р. 2315 2318.
References: [1-15]
1. Abramchenko V.V., Guseva E.N. Medikamentoznyi abort [Medical abortion]. Sankt-Peterburg: «ELBI-SPB», 2005. 288 p. [in Russian]
2. Ailamazyan E.K., Kulakov V.I., Savel'eva G.M. Akusherstvo. Natsional'noe rukovodstvo [Obstetrics. National leadership], M. GEOTAR-Media, 2009. pp. 332 339. [in Russian]
3. Belokrinitskaya T.E. i dr. Sravnitel'naya otsenka klinicheskogo techeniya medikamentoznogo aborta s 200 mg i 600 mg mifepristona: prospektivnoe kogortnoe issledovanie [Comparative evaluation of the clinical course of medical abortion with mifepristone 200 mg and 600 mg: a prospective cohort study]. Akusherstvo i ginekologiya [Obstetrics and Gynecology]. 2014. 3. pp. 81 86. [in Russian]
4. Dikke G.B., Yarotskaya V.A., Erofeeva A.V. Strategicheskaya otsenka politiki, programm i uslug v sfere neplaniruemoi beremennosti, abortov i kontratseptsii v Rossiiskoi Federatsii (Sovmestnoe issledovanie Ministerstva zdravookhraneniya i sotsial'nogo razvitiya RF i VOZ) [Strategic assessment of policies, programs and services in the field of unplanned pregnancy, abortion and contraception in the Russian Federation (Joint study of the Ministry of Health and Social Development of the Russian Federation and WHO)]. Problemy reproduktsii [Problems of reproduction]. 2010. 3. pp. 92 97. [in Russian]
5. Dostupnost' i bezopasnost' aborta i kontratseptsii: problemy obshchestvennogo zdravookhra-neniya [Availability and safety of abortion and contraception: public health issues]. Materialy mezhdunarodnogo seminara Fiapac. Moskva, GU Nauchnyi tsentr akusherstva, ginekologii i perinatologii RAMN [Materials of the international seminar Fiapac. Moscow, Scientific Center for Obstetrics, Gynecology and Perinatology of the Russian Academy of Medical Sciences], 2005. 335 p. [in Russian]
6. Kulakov V.I. Abort v Rossii: izmeneniya poslednikh 20 let [Abortion in Russia: Changes in the last 20 years]. Dostupnost' bezopasnogo aborta i kontratseptsii: problemy obshchestvennogo zdravookhraneniya: mezhdunar. seminar [Availability of safe abortion and contraception: problems of public health: Intern. seminar]. M., 2005. pp. 8 11. [in Russian]
7. Krasnopol'skii V.I., Mel'nik T.N., Serova O.F. Bezopasnyi abort. [Safe abortion]. M. GEOT AR-Media, 2009. 37p. [in Russian]
8. Meditsinskie kriterii priemlemosti metodov kontratseptsii RF [Medical criteria for the acceptability of RF contraceptive methods.]. Moskva, 2012. 242 p. [in Russian]
9. Prilepskaya V.N., Kuzemina A.A. Abort v I trimestre beremennosti [Abortion in the first trimester of pregnancy]. M., GEOTAR-Media, 2010. 210 p. [in Russian]
10. Prikaz Minzdrava Rossii ot 12 noyabrya 2012g. 572n. Poryadok okazaniya meditsinskoi pomoshchi po profilyu «akusherstvo i ginekologiya (za isklyucheniem ispol'zovaniya vspomogatel'nykh reproduktivnykh tekhnologii)» [Order of the Ministry of Health of Russia dated November 12, 2012 No. 572n. The procedure for providing medical care in the profile "obstetrics and gynecology (with the exception of the use of assisted reproductive technologies)". https://minzdrav.gov.ru (accessed 08.02.2013). [in Russian]
11. Prikaz Ministerstva zdravookhraneniya i sotsial'nogo razvitiya RF ot 17 maya 2007 g. N335 «O rekomenduemom obraztse informirovannogo dobrovol'nogo soglasiya na provedenie iskusstvennogo preryvaniya beremennosti pri sroke do 12 nedel'» [Order of the Ministry of Health and Social Development of the Russian Federation from April 7, 2016 N 216n "On the recommended sample of informed voluntary consent for artificial termination of pregnancy for up to 12 weeks https://www.dokipedia.ru (accessed 17.05.2016) [in Russian]
12. Serov V.N. Gormonal'naya kontratseptsiya kak metod reabilitatsii posle abortov [Hormonal contraception as a method of rehabilitation after abortion]. Ginekologiya [Gynecology]. 2010. №2. pp. 26-28. [in Russian]
13. Serova O.F., Mel'nik T.N., Lipoveyako L.N. Sovremennye tekhnologii preryvaniya beremennosti v rannie sroki [Modern technologies for abortion in the early stages]. Voprosy ginekologii, akusherstva i perinatologii [Issues of gynecology, obstetrics and perinatology]. 2003. 2 (1). pp. 87 90. [in Russian]
14. Savel'eva I.A. Medikamentoznyi abort: prakticheskie voprosy [Medical abortion: practical issues]. Effektivnaya farmakoterapiya v akusherstve i ginekologii [Effective pharmacotherapy in obstetrics and gynecology]. 2010. №3. p. 22. [in Russian]
15. Yavorovskaya K.A., Shchedrina R.N., Petrovich E. Rol' narushenii funktsii shchitovidnoi zhelezy v realizatsii programmy ekstrakorporal'nogo oplodotvoreniya i perenosa embrionov [The role of thyroid dysfunction in the implementation of the program of in vitro fertilization and embryo transfer]. Akusherstvo i ginekologiya [Obstetrics and Gynecology]. 2004. 6: 8–9. [in Russian]
Количество просмотров: 239
Категория статей:
Оригинальные исследования
Библиографическая ссылка
Sakhipova G.Zh., Abenova N.A. Ovarian hormonal stress after medical abortion // Nauka i Zdravookhranenie [Science & Healthcare]. 2022, (Vol.24) 6, pp. 32-39. doi 10.34689/SH.2022.24.6.005Похожие публикации:
МЕХАНИКАЛЫҚ САРҒАЮ ОПЕРАЦИЯСЫ КЕЗІНДЕ КОАГУЛОПАТИЯЛЫҚ ҚАН КЕТУДІҢ АЛДЫН АЛУ ӘДІСІ
ОПТИМИЗАЦИЯ РЕЗУЛЬТАТОВ АУТОДЕРМОПЛАСТИКИ ПРИ ЛЕЧЕНИИ ГРАНУЛИРУЮЩИХ ГНОЙНЫХ РАН
BASICS OF REHABILITATION OF CHILDREN AFTER OPERATIONS ON THE COLON AND ANORECTAL AREA
HEALTH INDICATORS OF FIRST-YEAR-OF-LIFE CHILDREN IN THE REPUBLIC OF KAZAKHSTAN FOR 2013-2022
ОЦЕНКА УДОВЛЕТВОРЕННОСТИ ТРУДОВОЙ ДЕЯТЕЛЬНОСТЬЮ ВРАЧЕЙ АНЕСТЕЗИОЛОГОВ-РЕАНИМАТОЛОГОВ ГОРОДА АСТАНА